CORRECTION

High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease

I

n the article by Seydelmann et al, “High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease,” which published online May 31, 2016, and appeared in the June 2016 issue of the journal (J Am Heart Assoc. 2016;5:e002839 doi: 10.1161/JAHA.115.002839), on page 1 of the HTML version, in the affiliations section, the

second affiliation was incorrectly written as Barcelona, Germany. It has now been corrected to Barcelona, Spain. The publisher regrets the error. The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/5/6/ e002839.full

J Am Heart Assoc. 2016;5:e002114 doi: 10.1161/JAHA.116.002114. ª 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.

DOI: 10.1161/JAHA.116.002114

Journal of the American Heart Association

1

High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease.

High-Sensitivity Troponin: A Clinical Blood Biomarker for Staging Cardiomyopathy in Fabry Disease. - PDF Download Free
157KB Sizes 1 Downloads 8 Views